Detection of lymph node metastases in pediatric and adolescent/young adult sarcoma: Sentinel lymph node biopsy versus fludeoxyglucose positron emission tomography imaging-A prospective trial
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Aug 2016 · 1 min read
In brief
In brief
This prospective trial compared sentinel lymph node biopsy with SPECT-CT versus PET-CT imaging for detecting nodal metastases in 28 pediatric and AYA sarcoma patients. SLNB identified nodal disease in 25% of patients, including 3 cases missed by PET-CT, while PET-CT showed low positive predictive value (29%) for histologically confirmed metastases.
Written by the GCMD Library team from the article.
Statements in this article
Lymph node metastases are an important cause of treatment failure for pediatric and adolescent/young adult sarcoma patients.
Nodal sampling is recommended for certain sarcoma subtypes that have a predilection for lymphatic spread.
A median of 2.4 sentinel nodes were sampled per patient.
No wound infections or chronic lymphedema occurred following sentinel lymph node biopsy.
Sentinel lymph node biopsy identified tumors in 7 of 28 patients (25%).
Sentinel lymph node biopsy identified nodal metastases in 3 patients who had normal PET-CT imaging of the nodal basin.
PET-CT demonstrated hypermetabolic regional nodes in 14 patients.
PET-CT had a positive predictive value of only 29% for detecting nodal metastases.